Halozyme Therapeutics shares owned by Wintrust Financial Corporation
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Wintrust Financial Corporation
from 13F filings
Historical chart of Wintrust Financial Corporation investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Wintrust Financial Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $8.9M | 121k | 73.34 |
| 2025-06-30 | $7.1M | 136k | 52.02 |
| 2025-03-31 | $10M | 162k | 63.81 |
| 2024-12-31 | $3.1M | 64k | 47.81 |
| 2024-09-30 | $4.7M | 82k | 57.24 |
| 2024-06-30 | $4.4M | 83k | 52.36 |
| 2024-03-31 | $3.7M | 90k | 40.68 |
| 2023-12-31 | $3.8M | 104k | 36.96 |
| 2023-09-30 | $6.1M | 160k | 38.20 |
| 2023-06-30 | $5.2M | 145k | 36.07 |
| 2023-03-31 | $6.5M | 169k | 38.19 |
More positions owned by Wintrust Financial Corporation
View all positions for Wintrust Financial Corporation